Henrik Hjorth-Hansen

10PUBLICATIONS
90CO-AUTHORS
Molecular targetsRegenerative medicine (incl. stem cells)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 18, 2026
Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study.

|Sep 16, 2025
Granulocyte abundance and maturation state at diagnosis predicts treatment-free remission in CML.

Mikko Purhonen, Mikael Tatun, Katariina Luukkainen

|Jul 11, 2025
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.

Jane F Apperley, Dragana Milojkovic, Nicholas C P Cross

|Jan 10, 2025
High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia.

Petra Nygrén, Jonas Bouhlal, Emmi Jokinen

|Nov 06, 2024
Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response.

Rebecca Warfvinge, Linda Geironson Ulfsson, Parashar Dhapola

|Aug 20, 2024
Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial.

Carlo Gambacorti-Passerini, Tim H Brümmendorf, Elisabetta Abruzzese

Pageof 2

Frequent Collaborators

5 joint publications

Satu Mustjoki

5 joint publications

Susanne Saußele

4 joint publications

Johan Richter

4 joint publications

Tim H Brümmendorf